Impact of Secondary Amenorrhea on Cardiovascular Disease Risk in Physically Active Women: A Systematic Review and Meta‐Analysis
Open Access
- 19 March 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (6) , e033154
Abstract
Background: Exercise‐associated secondary amenorrhea results in estrogen deficiency, which may lead to dysfunction in estrogen's normal cardioprotective pathways. Estrogen may be essential in a woman's endothelial adaptations to exercise. The objective of this review was to assess the association between secondary amenorrhea in physically active women and cardiovascular disease (CVD) risk. Methods and Results: A literature search was performed in January 2023 and updated in August 2023 of the Cumulative Index to Nursing and Allied Health Literature (EBSCOhost), Cochrane Library, Embase (Ovid), MEDLINE (Ovid), SPORTDiscus (EBSCOhost), and Scopus from inception to present with no date or language limitations. Citation chaining was done to screen for additional studies. Eight sources were searched for gray literature. Studies that compared physically active women with amenorrhea to physically active women with eumenorrhea aged 18 to 35 years with evidence of CVD, alterations to cardiovascular physiology, or CVD risks were included. Eighteen observational studies from 3 countries were included. Overall, the quality of evidence was good. A meta‐analysis was performed. Physically active women with secondary amenorrhea had significantly lower estradiol, flow‐mediated dilation, resting heart rate, systolic blood pressure, and diastolic blood pressure and higher total cholesterol, triglycerides, high‐density lipoprotein, and low‐density lipoprotein cholesterol. Conclusions: Estrogen deficiency resulting from exercise‐associated secondary amenorrhea in physically active women may impact cardiovascular physiology and certain CVD risk factors. The research in this area is observational; therefore, findings should be interpreted cautiously. However, as exercise‐associated secondary amenorrhea is reversible and the primary prevention of CVD is important for public health, it may be important to treat secondary amenorrhea and restore estrogen levels.Keywords
This publication has 62 references indexed in Scilit:
- Canadian Society of Clinical Chemists Harmonized Clinical Laboratory Lipid Reporting Recommendations on the Basis of the 2021 Canadian Cardiovascular Society Lipid GuidelinesCanadian Journal of Cardiology, 2022
- Analysing data and undertaking meta‐analyses2019
- Current Status of the Female Athlete Triad: Update and Future DirectionsCurrent Osteoporosis Reports, 2017
- Subclinical atherosclerotic risk in endurance-trained premenopausal amenorrheic womenAtherosclerosis, 2016
- From endothelial dysfunction to atherosclerosisAutoimmunity Reviews, 2010
- Secondary Amenorrhea2006
- Coronary risk factors, endothelial function, and atherosclerosis: A reviewClinical Cardiology, 1997
- Physical Fitness and All-Cause MortalityJAMA, 1989
- Prevalence of oligomenorrhea and amenorrhea in a college populationAmerican Journal of Obstetrics and Gynecology, 1982
- Epidemiology of secondary amenorrheaAmerican Journal of Obstetrics and Gynecology, 1973